Malignant intercostal psammomatous melanotic schwannoma in a patient with Carney complex

Article information

Korean J Intern Med. 2018;33(6):1256-1257
Publication date (electronic) : 2017 November 15
doi : https://doi.org/10.3904/kjim.2017.139
1Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea
2Department of Pathology, Chungnam National University School of Medicine, Daejeon, Korea
3Department of Cancer Research Institute, Chungnam National University School of Medicine, Daejeon, Korea
4Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
Correspondence to Hyun Jin Kim, M.D. Tel: +82-42-280-7151 Fax: +82-42-280-7995 E-mail: kimhj43@cnuh.co.kr
Received 2017 March 15; Revised 2017 May 30; Accepted 2017 May 30.

A 40-year-old woman who experienced progressive right abdominal pain for 1 month was admitted to our hospital. The patient and her family members were diagnosed with Carney complex (CNC). Two years prior to admission, the patient underwent percutaneous needle biopsy of a newly diagnosed intercostal mass near segment V of the liver by computed tomography (CT) (Fig. 1A) and biopsy suggested the presence of psammomatous melanotic schwannoma (PMS). At admission, CT images showed a 3.9 × 1.5 cm mass with ill-defined (Fig. 1B). The size of the mass increased by 1.9 cm in 2 years, and newly occurring calcification was present. Laparoscopic tumor resection was performed. The tumor biopsy revealed a distinct transition between the hypercellular epithelioid central and hypocellular spindle peripheral zones (Fig. 1C), together with the melanin-containing spindle cells and psammoma bodies, stained positively for HMB45 (Fig. 1D). Based on positive staining for S-100 protein (Fig. 1E), and vimentin, the tumor was diagnosed as a malignant PMS. The 2-[fluorine-18]-fluoro-2-deoxy-D-glu-cose-positon emission tomography/CT (FDG-PET/CT) performed at the initial diagnosis of PMS, showed no significant FDG uptake (Fig. 2A); however, at admission, intense FDG uptake in the intercostal mass was observed (Fig. 2B). Approximately 3 years after the diagnosis of PMS, the patient suffered from tumor growth and distant metastasis (Fig. 2C-2G), and died despite adjuvant chemotherapy and radiotherapy.

Figure 1.

Changes in the size of the intercostal mass on contrast-enhanced abdominal/pelvic computed tomography (CT) and pathologic findings of the intercostal mass. (A) At the initial diagnosis of psammomatous melanotic schwannoma, 2 years prior to admission, a 2.5-cm-sized hypoechoic nodule on abdominal/pelvic CT was revealed next to the V segment of the liver. (B) At admission, a 4.0-cm-sized, irregularly shaped, hypoechoic nodule with calcification was revealed on abdominal/pelvic CT. All arrows indicated the intercostal mass. (C) The malignant melanotic schwannoma showing a distinct transition between the hypercellular epithelioid central and hypocellular spindle peripheral zones was stained with hematoxylin and eosin (×200). (D) The melanin-containing spindle cells bodies stained positively for HMB45 (×200). (E) The tumor cells were strongly immunopositive for S-100 protein.

Figure 2.

Changes on 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positon emission tomography/computed tomography (FDGPET/CT) images according to disease progression. (A) At the initial diagnosis of psammomatous melanotic schwannoma, 2 years prior to admission, there was no significant glucose uptake on PET-CT. (B) At admission, PET/CT images revealed intense FDG uptake in the intercostal mass, but without distant metastasis. (C, D, E, F, G) After resection of the tumor, follow-up PET-CT images showed an aggravated state with multiple malignant masses in both lungs, right pleura, bones, and soft tissue.

The PMS tumors has been described in isolated cases or, more frequently, in cases of CNC. Although malignant PMS of the spine has been described in patients with CNC, malignant intercostal PMS in CNC has not been reported in the literature to date, to the best our knowledge. Based on our case, we suggest that early complete resection of PMS and rigorous follow-up are necessary for patients with CNC due to the risk of malignant transformation.

Notes

No potential conflict of interest relevant to this article was reported.

Article information Continued

Figure 1.

Changes in the size of the intercostal mass on contrast-enhanced abdominal/pelvic computed tomography (CT) and pathologic findings of the intercostal mass. (A) At the initial diagnosis of psammomatous melanotic schwannoma, 2 years prior to admission, a 2.5-cm-sized hypoechoic nodule on abdominal/pelvic CT was revealed next to the V segment of the liver. (B) At admission, a 4.0-cm-sized, irregularly shaped, hypoechoic nodule with calcification was revealed on abdominal/pelvic CT. All arrows indicated the intercostal mass. (C) The malignant melanotic schwannoma showing a distinct transition between the hypercellular epithelioid central and hypocellular spindle peripheral zones was stained with hematoxylin and eosin (×200). (D) The melanin-containing spindle cells bodies stained positively for HMB45 (×200). (E) The tumor cells were strongly immunopositive for S-100 protein.

Figure 2.

Changes on 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positon emission tomography/computed tomography (FDGPET/CT) images according to disease progression. (A) At the initial diagnosis of psammomatous melanotic schwannoma, 2 years prior to admission, there was no significant glucose uptake on PET-CT. (B) At admission, PET/CT images revealed intense FDG uptake in the intercostal mass, but without distant metastasis. (C, D, E, F, G) After resection of the tumor, follow-up PET-CT images showed an aggravated state with multiple malignant masses in both lungs, right pleura, bones, and soft tissue.